Skip to content

The effect of Siriraj Ayurved Harak recipe (AVS022) on platelet aggregation in Thai healthy volunteers: a randomized, placebo, controlled trial

The effect of Siriraj Ayurved Harak recipe (AVS022) on platelet aggregation in Thai healthy volunteers: a randomized, placebo, controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20141212003
Enrollment
Unknown
Registered
2014-12-12
Start date
2010-09-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Platelet aggregation Thai traditional medicine complimentary and alternative medicine Siriraj Ayurved recipe (AVS022) platelet aggregation adrenaline ADP collagen

Interventions

1500 mg oral every 8 hours for total 3 doses,oral route every 8 hours for 3 times
Active Comparator Other,Placebo Comparator Other
AVS022,Placebo

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Lead Sponsor
Thailand Research Fund (TRF)
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Male and female age between 18 and 45 years, considered healthy based on medical history, physical examination and laboratory test (hematology, blood biochemistry, lipid profiles, urine analysis and urine pregnancy test in only female volunteers).

Exclusion criteria

Exclusion criteria: Subject who takes drugs that affect platelet function such as aspirin,clopidogrel, etc. or has a history of drug allergy especially antipyretic drug including paracetamol or Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) or participated in other research less than 1 month from the enrollment date.

Design outcomes

Primary

MeasureTime frame
Platelet aggregation before dose and at 8, 32 hours and 7-10 days after the first dose the percentage of platelet aggregation

Secondary

MeasureTime frame
AVS022 safety after dosing until 7-10 days after dose rate and type of adverse events

Countries

Thailand

Contacts

Public ContactWeerawadee Chandranipapongse

Faculty of Medicine Siriraj Hospital, Mahidol University

weerawadee.cha@mahidol.ac.th024195253

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026